Literature DB >> 9043745

Alfentanil mediated activation of epileptiform activity in the electrocorticogram during resection of epileptogenic foci.

D L Keene1, D Roberts, W M Splinter, M Higgins, E Ventureyra.   

Abstract

PURPOSE: Alfentanil is a potent, short-acting opioid agent which has been used during balanced anaesthesia in children undergoing the surgical excision of epileptic foci. After the observation that this agent had the potential to induce epileptic seizures, we questioned the frequency of this occurrence in this group of patients.
METHOD: Twelve patients (6 males, 6 females) undergoing surgical excision of an epileptic foci were prospectively followed. For each patient an electrocorticogram was recorded for 30 minutes before and after receiving alfentanil 20 micrograms/kg intravenously. The frequency of epileptiform abnormalities before and after drug administration was evaluated. When the electrocorticogram no longer showed the effects of alfentanil administration, methohexital 0.5 microgram/kg was given intravenously.
RESULTS: Alfentanil induced significant activation of epileptiform discharges among 83% of these patients. Twenty-five per cent had an electrographic seizure. In comparison, methohexital induced significant activation of epileptiform discharges in 50% of these patients. None experienced electrographic seizures.
CONCLUSIONS: As alfentanil can induce electrographic seizures in patients known to have epilepsy, caution is advised in its use in this group of patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9043745

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  2 in total

1.  Techniques for placement of grid and strip electrodes for intracranial epilepsy surgery monitoring: Pearls and pitfalls.

Authors:  Jason M Voorhies; Aaron Cohen-Gadol
Journal:  Surg Neurol Int       Date:  2013-07-26

2.  Application of Awake Surgery for Epilepsy in Clinical Practice.

Authors:  Satoshi Maesawa; Daisuke Nakatsubo; Masazumi Fujii; Kentaro Iijima; Sachiko Kato; Tomotaka Ishizaki; Masashi Shibata; Toshihiko Wakabayashi
Journal:  Neurol Med Chir (Tokyo)       Date:  2018-09-21       Impact factor: 1.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.